Carasent AB Stock Oslo Bors
Stocks
CARA
SE0023261599
Advanced Medical Equipment & Technology
OTC Markets Traded|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.10 NOK | +3.94% |
|
-.--% | - |
| 06-11 | Lannebo Hälsa och Ny Teknik rose 3.6 percent in May: Raysearch Laboratories, Sectra, and Bioinvent contributed positively | FW |
| 06-09 | Carasent completes acquisition of Infosolutions | FW |
| Market Cap | 1.59B 168M 145M 133M 125M 234M 15.93B 238M 1.57B 614M 7.75B 629M 615M 26.84B | P/E Ratio 2026 * |
52.9x | P/E Ratio 2027 * | 27.7x |
|---|---|---|---|---|---|
| Enterprise Value | 1.49B 157M 136M 125M 117M 220M 14.97B 223M 1.48B 577M 7.28B 591M 578M 25.22B | EV / Sales 2026 * |
3.75x | EV / Sales 2027 * | 2.98x |
| Free-Float |
66.22% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Carasent AB
| 1 day | +3.94% |
| 3 years | 9.81 |  | 21.3 |
| 5 years | 9.81 | | 51 |
| 10 years | 2 | | 51 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.94% | -.--% | - | - | 168M | |
| -1.24% | -7.57% | -43.54% | -16.41% | 25.92B | |
| +0.74% | -0.99% | -39.37% | +150.96% | 12.08B | |
| -0.07% | +3.07% | -3.76% | +54.63% | 6.19B | |
| +8.38% | +18.29% | - | - | 2.87B | |
| +0.03% | -12.02% | +29.33% | -47.78% | 1.72B | |
| -4.25% | -3.81% | - | - | 1.59B | |
| +2.32% | -0.30% | -30.41% | - | 1.29B | |
| +0.57% | -4.31% | -33.27% | -59.98% | 813M | |
| +3.19% | +0.46% | -28.16% | +214.12% | 803M | |
| Average | +1.36% | -0.82% | -21.31% | +49.26% | 5.92B | |
| Weighted average by Cap. | +0.01% | -3.16% | -34.12% | +37.41% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 398M 41.96M 36.24M 33.4M 31.26M 58.58M 3.99B 59.49M 394M 154M 1.94B 157M 154M 6.72B | 476M 50.12M 43.29M 39.89M 37.34M 69.98M 4.76B 71.06M 471M 184M 2.32B 188M 184M 8.03B |
| Net income | 31.63M 3.33M 2.88M 2.65M 2.48M 4.65M 317M 4.73M 31.32M 12.21M 154M 12.51M 12.24M 534M | 60.18M 6.34M 5.48M 5.05M 4.72M 8.85M 603M 8.99M 59.6M 23.24M 293M 23.8M 23.29M 1.02B |
| Net Debt | -95.93M -10.11M -8.73M -8.05M -7.53M -14.11M -961M -14.33M -95M -37.04M -468M -37.94M -37.13M -1.62B | -171M -18.01M -15.55M -14.33M -13.41M -25.14M -1.71B -25.53M -169M -65.98M -833M -67.58M -66.14M -2.88B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CARA Stock
- CARA Stock
Select your edition
All financial news and data tailored to specific country editions
